Stock listing
ASX:PCK PainChek Ltd Share Price
Follow PainChek Ltd into a list and get an email when it puts out news.
Share price · ASX:PCK
$0.064 AUD -0.003 (-4.5%)
Close on Nov 20, 2026
- Day range
- $0.060 – $0.064 AUDNov 20, 2026
- Volume
- 21,526 sharesNov 20, 2026
- Market cap
- $13.39M AUDAt the close on Nov 20, 2026 · price × 209.2M shares outstanding
- 52-week range
- $0.060 – $0.400 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $13,165 AUDMedian day 72,866 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:PCK · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.064 | -0.003 | -4.5% | $0.060 | $0.064 | $0.060 | 21,526 | |
| $0.067 | -0.001 | -1.5% | $0.067 | $0.067 | $0.065 | 163,533 | |
| $0.068 | 0.000 | 0.0% | $0.068 | $0.068 | $0.068 | 20,888 | |
| $0.068 | -0.001 | -1.4% | $0.070 | $0.071 | $0.068 | 202,366 | |
| $0.069 | -0.001 | -1.4% | $0.069 | $0.069 | $0.069 | 25,604 | |
| $0.070 | -0.003 | -4.1% | $0.069 | $0.070 | $0.069 | 68,517 | |
| $0.073 | +0.003 | +4.3% | $0.070 | $0.073 | $0.069 | 181,200 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 | |
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 | |
| $0.070 | +0.002 | +2.9% | $0.068 | $0.070 | $0.068 | 83,147 | |
| $0.068 | -0.007 | -9.3% | $0.074 | $0.074 | $0.067 | 31,839 | |
| $0.075 | +0.008 | +11.9% | $0.068 | $0.075 | $0.068 | 21,558 | |
| $0.067 | -0.011 | -14.1% | $0.070 | $0.070 | $0.067 | 30,575 | |
| $0.078 | +0.008 | +11.4% | $0.070 | $0.078 | $0.070 | 54,717 | |
| $0.070 | -0.004 | -5.4% | $0.074 | $0.074 | $0.070 | 239,770 | |
| $0.074 | +0.004 | +5.7% | $0.082 | $0.082 | $0.074 | 152,586 | |
| $0.070 | -0.003 | -4.1% | $0.070 | $0.070 | $0.065 | 320,392 | |
| $0.073 | -0.005 | -6.4% | $0.078 | $0.080 | $0.070 | 151,263 | |
| $0.078 | -0.010 | -11.4% | $0.088 | $0.088 | $0.078 | 1,049,576 | |
| $0.088 | -0.001 | -1.1% | $0.088 | $0.088 | $0.088 | 6,420 | |
| $0.089 | -0.001 | -1.1% | $0.092 | $0.092 | $0.089 | 121,976 | |
| $0.090 | +0.002 | +2.3% | $0.090 | $0.090 | $0.090 | 32,222 | |
| $0.088 | -0.005 | -5.4% | $0.092 | $0.092 | $0.088 | 39,319 | |
| $0.093 | +0.001 | +1.1% | $0.095 | $0.097 | $0.089 | 241,443 | |
| $0.092 | +0.002 | +2.2% | $0.097 | $0.097 | $0.089 | 353,884 | |
| $0.090 | +0.004 | +4.7% | $0.095 | $0.095 | $0.090 | 231,698 | |
| $0.086 | -0.013 | -13.1% | $0.100 | $0.140 | $0.086 | 1,629,346 | |
| $0.099 | +0.004 | +4.2% | $0.095 | $0.099 | $0.095 | 19,435 | |
| $0.095 | -0.001 | -1.0% | $0.095 | $0.095 | $0.095 | 218 | |
| $0.096 | 0.000 | 0.0% | $0.096 | $0.096 | $0.094 | 185,273 | |
| $0.096 | 0.000 | 0.0% | $0.096 | $0.096 | $0.094 | 143,156 | |
| $0.096 | -0.001 | -0.5% | $0.096 | $0.096 | $0.096 | 15,924 | |
| $0.097 | 0.000 | 0.0% | $0.097 | $0.097 | $0.097 | 0 | |
| $0.097 | +0.002 | +1.6% | $0.095 | $0.097 | $0.095 | 131,429 | |
| $0.095 | -0.001 | -1.0% | $0.098 | $0.099 | $0.095 | 76,461 | |
| $0.096 | 0.000 | 0.0% | $0.096 | $0.096 | $0.096 | 77,829 | |
| $0.096 | -0.001 | -1.0% | $0.096 | $0.096 | $0.096 | 1,000 | |
| $0.097 | 0.000 | 0.0% | $0.097 | $0.097 | $0.097 | 34,158 | |
| $0.097 | 0.000 | 0.0% | $0.097 | $0.097 | $0.097 | 7,500 | |
| $0.097 | -0.008 | -7.6% | $0.105 | $0.105 | $0.096 | 21,139 | |
| $0.105 | -0.005 | -4.5% | $0.105 | $0.105 | $0.105 | 75,540 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 87,672 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 2,588 | |
| $0.110 | -0.005 | -4.3% | $0.115 | $0.115 | $0.110 | 34,108 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 398 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 5,000 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 173,266 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.120 | $0.115 | 46,231 | |
| $0.115 | -0.010 | -8.0% | $0.115 | $0.125 | $0.115 | 100,388 | |
| $0.125 | 0.000 | 0.0% | $0.130 | $0.130 | $0.125 | 77,936 | |
| $0.125 | +0.010 | +8.7% | $0.120 | $0.130 | $0.120 | 190,874 | |
| $0.115 | +0.005 | +4.5% | $0.110 | $0.115 | $0.110 | 100,684 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.105 | 70,191 | |
| $0.110 | +0.005 | +4.8% | $0.105 | $0.110 | $0.105 | 95,255 | |
| $0.105 | +0.009 | +9.4% | $0.100 | $0.105 | $0.100 | 94,055 | |
| $0.096 | -0.002 | -2.0% | $0.096 | $0.125 | $0.096 | 1,478,284 | |
| $0.098 | +0.003 | +3.2% | $0.095 | $0.098 | $0.095 | 28,019 | |
| $0.095 | +0.001 | +1.1% | $0.095 | $0.095 | $0.095 | 68,126 | |
| $0.094 | 0.000 | 0.0% | $0.094 | $0.094 | $0.094 | 3,745 | |
| $0.094 | 0.000 | 0.0% | $0.094 | $0.094 | $0.094 | 251 | |
| $0.094 | +0.001 | +1.1% | $0.093 | $0.095 | $0.092 | 129,443 | |
| $0.093 | 0.000 | 0.0% | $0.093 | $0.093 | $0.093 | 52,439 | |
| $0.093 | -0.005 | -5.1% | $0.097 | $0.098 | $0.092 | 372,063 | |
| $0.098 | -0.001 | -1.0% | $0.100 | $0.100 | $0.098 | 85,480 | |
| $0.099 | -0.001 | -1.0% | $0.097 | $0.100 | $0.097 | 162,005 |
Splits
2 splits since 2016 · ASX:PCK · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 4-for-7 | Consolidation |
- Ticker
- ASX:PCK
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 4, 2026
Results of Meeting
Latest deck · Nov 4, 2026
Shareholder Meeting (November 2026)
Shareholder meeting · 14 slides
Latest news
Results of Meeting
Nov 4, 2026
Closed $0.07 (+2.9%) on Nov 5, 2026
Chair's Address to Shareholders and CEO presentation
Nov 3, 2026
Closed $0.068 (-9.3%) on Nov 4, 2026
PCK AGM watching the live feed
Nov 1, 2026
Closed $0.067 (-14.1%) on Nov 2, 2026
Final Director's Interest Notice
Oct 30, 2026
Closed $0.078 (+11.4%) on Oct 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 27, 2026
Closed $0.074 (+5.7%) on Oct 28, 2026
PainChek wins 1,800-licence UK contract with Hallmark
Oct 26, 2026
Closed $0.07 (-4.1%) on Oct 27, 2026
John Murray retires as PainChek non-executive director
Oct 25, 2026
Closed $0.073 (-6.4%) on Oct 26, 2026
Notification regarding unquoted securities - PCK
Oct 12, 2026
Closed $0.086 (-13.1%) on Oct 13, 2026
PainChek expands Sabra contracts to 23 US communities
Oct 12, 2026
Closed $0.086 (-13.1%) on Oct 13, 2026
Change of Director's Interest Notice x3
Sep 30, 2026
Closed $0.096 (0.0%) on Sep 30, 2026
PainChek Ltd on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 34 in the last 12 months · 156 in all · newest Nov 4, 2026 · oldest 2016
- Decks
- 30 decks · latest Nov 4, 2026
Cash and shares
Oct 2025 deck · PainChek — Investor Presentation (October 2025)
- Cash
- A$6.3 million
Valuation
EV/sales 3.1× against a median of 5.4×: 5th lowest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $11.65M AUD
- P/E
- Loss
- EV/sales
- 3.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- 70.5%
- Operating margin
- −265.0%
- Net margin
- −238.8%
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PainChek Ltd · ASX:PCK | US$8.86M | US$7.71M | n/a | 3.1× | n/a | n/a | −238.8% | n/a | n/a |
| Concord Medical Services Holdings Ltd. · NYSE:CCM | US$9.99M | US$510.9M | n/a | 7.4× | n/a | n/a | −20.2% | n/a | 0.49 |
| Vidavo SA · ATHEX:VIDAVO | US$9.78M | US$8.25M | 15.0× | 3.5× | 9.2× | 4.1× | 27.4% | 0.0× | n/a |
| AIML Innovations Inc · CSE:AIML | US$9.68M | US$11.23M | n/a | 368× | n/a | n/a | n/a | n/a | 0.33 |
| UCrest Bhd · MYX:UCREST | US$9.05M | US$6.78M | 138× | 2.0× | 34.7× | 0.9× | 1.9% | 0.0× | n/a |
| HeartSciences Inc. · NASDAQ:HSCS | US$8.99M | US$8.96M | n/a | 1,984× | n/a | n/a | n/a | n/a | 1.23 |
| Good Fellow Healthcare Holdings Limited · HKEX:8143 | US$8.53M | US$6.81M | n/a | 2.7× | n/a | 8.2× | −62.4% | 0.1× | n/a |
| KDA Group Inc. · TSXV:KDA | US$8.51M | US$8.34M | n/a | 28.6× | n/a | 2.0× | n/a | 0.0× | -0.76 |
| InteliCare Holdings Limited · ASX:ICR | US$8.05M | US$8.25M | n/a | 13.0× | n/a | n/a | −234.6% | n/a | n/a |
| SEI Medical Public Co., Ltd. · SET:SEI | US$7.91M | US$4.28M | 8.7× | 0.3× | 2.5× | 0.9× | 7.5% | 0.0× | n/a |
| Medicskin Holdings Ltd. · HKEX:8307 | US$7.85M | US$6.33M | 65.7× | 1.0× | 6.6× | 11.8× | 2.0% | 3.4× | n/a |
| Median of the others | US$8.76M | US$8.25M | 40.4× | 5.4× | 7.9× | 3.1× | 1.9% | 0.0× | 0.41 |
Team and board
Officers
| Officer | Role |
|---|---|
| Karen Holzberger | Chief Executive Officer |
| Iain McAdam | Chief Financial Officer |
| Andy Hoggan | Chief Operating Officer |
| Natalie Climo | Company Secretary |
| Christelle Ucinek | Head of Business Development, ANZ |
| Jeff Hughes | Chief Scientific Officer |
| Joseph Farmborough | Chief Technology and Innovation Officer |
| Sasha Grant | Head of Growth, PainChek Infant App |
| Tandeep Gill | General Manager & Head of Business Development, UK&I |
Board
| Director | Role |
|---|---|
| Lil Bianchi | Non-Executive Director and Non-Executive Chair of the Board |
| Adam Davey | Non-Executive Director |
| Cynthia Payne | Non-Executive Director |
| John Murray | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 28, 2025 | 0.0% |
| Q2 2025 | Feb 27, 2025 | −9.1% |
| Q2 2023 | Feb 28, 2023 · After close | −3.6% |
| Q4 2022 | Aug 30, 2022 · After close | 0.0% |
| Q2 2022 | Feb 27, 2022 · After close | −2.4% |
| Q4 2021 | Aug 30, 2021 · After close | −4.0% |
| Q2 2021 | Feb 25, 2021 · Before open | −3.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (November 2026) | Shareholder meeting | 14 slides | Nov 4, 2026 |
| Shareholder Meeting (November 2025) | Shareholder meeting | 28 slides | Nov 26, 2025 |
| Investor Presentation (October 2025) | Investor deck | 27 slides | Oct 31, 2025 |
| Investor Presentation (July 2025) | Investor deck | 34 slides | Jul 28, 2025 |
| Earnings Presentation (May 2025) | Earnings | 32 slides | May 1, 2025 |
| Q1 FY25 Earnings Presentation | Earnings | 32 slides | Oct 30, 2024 |
| Investor Presentation (July 2024) | Investor deck | 41 slides | Jul 30, 2024 |
| Investor Presentation (January 2024) | Investor deck | 35 slides | Jan 30, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 23 slides | Nov 22, 2023 |
| Investor Presentation (October 2023) | Investor deck | 23 slides | Oct 31, 2023 |
All 30 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2023) | Investor deck | 42 slides | Sep 14, 2023 |
| Corporate Update (July 2023) | Corporate update | 32 slides | Jul 27, 2023 |
| Investor Presentation (May 2023) | Investor deck | 38 slides | May 2, 2023 |
| Investor Presentation (January 2023) | Investor deck | 26 slides | Jan 31, 2023 |
| Shareholder Meeting (November 2022) | Shareholder meeting | 24 slides | Nov 23, 2022 |
| Investor Presentation (August 2022) | Investor deck | 31 slides | August 2022 |
| Investor Presentation (June 2022) | Investor deck | 34 slides | Jun 24, 2022 |
| Corporate Update (May 2022) | Corporate update | 24 slides | May 3, 2022 |
| Corporate Update (January 2022) | Corporate update | 27 slides | Jan 28, 2022 |
| Webinar: Pain and Dementia (October 2021) | Conference | 21 slides | Oct 27, 2021 |
| Corporate Update (January 2021) | Corporate update | 22 slides | Jan 22, 2021 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 16 slides | Nov 26, 2020 |
| Conference Presentation (August 2020) | Conference | 26 slides | Aug 3, 2020 |
| NWR Communications Virtual Health Conference (May 2020) | Conference | 25 slides | May 1, 2020 |
| Investor Presentation (November 2019) | Investor deck | 19 slides | Nov 28, 2019 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 13 slides | Nov 20, 2019 |
| Investor Presentation (March 2019) | Investor deck | 22 slides | Mar 12, 2019 |
| Investor Presentation (October 2018) | Investor deck | 31 slides | Oct 16, 2018 |
| Investor Presentation (September 2018) | Investor deck | 29 slides | Sep 11, 2018 |
| Investor Presentation (May 2018) | Investor deck | 29 slides | May 17, 2018 |
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.74M | 3.36M | 2.67M | 1.95M | 978.6K | 214.8K | 248.2K | 215.5K | 50.6K | 31.1K |
| Cost of revenue | 1.10M | 2.36M | 1.95M | 1.24M | 1.24M | 639.0K | 265.2K | 265.2K | 1.71M | 150 |
| Gross profit | 2.64M | 997.7K | 726.7K | 712.5K | -258.8K | -424.2K | -17.0K | 215.5K | -1.66M | 31.0K |
| Research and development | 3.32M | 3.78M | 4.57M | 3.82M | 2.35M | 2.65M | 2.27M | 1.89M | 1.70M | 821.4K |
| Selling, general and administrative | 8.63M | 3.22M | 3.40M | 3.54M | 3.05M | 3.80M | 10.8M | 1.40M | 1.34M | 3.01M |
| Operating income | -9.92M | -9.11M | -9.51M | -8.76M | -7.59M | -8.97M | -15.0M | -3.26M | -4.81M | -4.01M |
| Depreciation and amortization | 13.2K | 18.2K | 25.6K | 17.0K | 14.4K | 59.5K | 43.0K | 3.17K | 4.03K | 150 |
| EBITDA | -9.90M | -9.09M | -9.49M | -8.75M | -7.57M | -8.91M | -15.0M | -3.26M | -4.81M | -4.00M |
| Interest expense | 196.6K | 15.6K | 0 | 0 | 0 | 0 | 0 | |||
| Income before tax | -10.1M | -7.67M | -8.31M | -8.62M | -6.81M | -7.12M | -13.2M | -3.26M | -4.81M | -8.47M |
| Income tax | -1.12M | -1.41M | -1.21M | -1.05M | -1.09M | -1.06M | -798.8K | -745.3K | 0 | -31.3K |
| Net income | -8.94M | -7.67M | -8.31M | -7.57M | -5.72M | -6.06M | -12.4M | -3.26M | -4.81M | -8.47M |
| Earnings per share, basic | -0.04 | -0.04 | -0.06 | -0.01 | -0.05 | -0.01 | -0.01 | -0.00 | -0.01 | -0.16 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.99M | 1.62M | 3.56M | 2.51M | 6.14M | 11.4M | 6.12M | 4.56M | 3.61M | 2.63M |
| Receivables | 1.53M | 446.0K | 521.7K | 201.7K | 436.8K | 315.8K | 69.1K | 161.3K | 56.1K | 45.0K |
| Inventory | -166.5K | 1 | 48.0K | 57.1K | 8.51K | -161.3K | -56.1K | |||
| Current assets | 7.61M | 2.13M | 4.15M | 2.77M | 6.63M | 11.8M | 6.20M | 4.73M | 3.67M | 2.69M |
| Property, plant and equipment | 19.5K | 29.4K | 22.8K | 26.2K | 18.5K | 18.0K | 15.7K | 4.38K | 2.54K | |
| Total assets | 7.63M | 2.15M | 4.18M | 2.80M | 6.65M | 11.8M | 6.22M | 4.75M | 3.67M | 2.69M |
| Accounts payable | 833.0K | 801.7K | 842.9K | 498.6K | 275.5K | 325.1K | 231.2K | 202.1K | 287.0K | 104.5K |
| Current liabilities | 7.67M | 3.26M | 2.89M | 2.13M | 1.83M | 3.57M | 2.09M | 628.4K | 447.9K | 207.2K |
| Total debt | 4.25M | |||||||||
| Total liabilities | 9.06M | 3.26M | 2.89M | 2.13M | 1.83M | 3.57M | 2.09M | 628.4K | 447.9K | 207.2K |
| Shareholders' equity | -1.43M | -1.11M | 1.29M | 668.1K | 4.82M | 8.24M | 4.13M | 4.12M | 3.22M | 2.48M |
| Shares outstanding | 206.1M | 173.7M | 148.1M | 1.29B | 112.8M | 1.12B | 992.3M | 841.1M | 800.9M | 52.1M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -9.24M | -6.75M | -7.13M | -6.32M | -7.00M | -4.12M | -1.89M | -3.07M | -2.91M | -1.58M |
| Capital spending | -14.9K | -12.2K | -34.3K | -13.6K | -22.0K | -60.0K | -45.6K | -14.5K | -5.87K | -5.87K |
| Free cash flow | -9.25M | -6.77M | -7.16M | -6.34M | -7.02M | -4.18M | -1.93M | -3.09M | -2.92M | -1.58M |
| Cash from investing | -14.9K | -12.2K | -34.3K | -12.4K | -22.0K | -60.0K | -45.6K | -14.5K | -5.87K | 18.3K |
| Cash from financing | 13.6M | 4.82M | 8.21M | 2.70M | 1.75M | 9.48M | 3.51M | 4.05M | 3.90M | 4.11M |
| Dividends paid | -8.23M | |||||||||
| Share buybacks | 5.12M | -459.9K | -126.6K | -198.0K | -522.8K | -55.7K | -168.8K | 4.12M | 4.73M | |
| Change in cash | 4.38M | -1.94M | 1.05M | -3.63M | -5.28M | 5.30M | 1.56M | 956.4K | 976.1K | 2.55M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Results of Meeting | Nov 4, 2026 | Meeting outcome | ASX |
| Chair's Address to Shareholders and CEO presentation | Nov 3, 2026 | Meeting outcome | ASX |
| PCK AGM watching the live feed | Nov 1, 2026 | Meeting notice | ASX |
| Final Director's Interest Notice | Oct 30, 2026 | Ownership change notice | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
| PainChek wins 1,800-licence UK contract with Hallmark | Oct 26, 2026 | Operations update | ASX |
| John Murray retires as PainChek non-executive director | Oct 25, 2026 | Management or board change | ASX |
| Notification regarding unquoted securities - PCK | Oct 12, 2026 | Other filings | ASX |
| PainChek expands Sabra contracts to 23 US communities | Oct 12, 2026 | Operations update | ASX |
All 156 filings
Cap table
Built by 6ix from PainChek Ltd’s releases
- Common shares
- 209,249,442
- Fully diluted
- 209,249,442
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 209,249,442 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 209,249,442 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adam Davey | Non-Executive Director · Since at least Sep 22, 2026 |
| Andy Hoggan | Chief Operating Officer · Since at least Nov 4, 2026 |
| Christelle Ucinek | Head of Business Development, ANZ · Since at least Nov 5, 2026 |
| Cynthia Payne | Non-Executive Director · Since at least Sep 22, 2026 |
| Iain McAdam | Chief Financial Officer · Since at least Nov 5, 2026 |
| Jeff Hughes | Chief Scientific Officer · Since at least Nov 4, 2026 |
| John Murray | Non-Executive Director · Since at least Oct 25, 2026 |
| Joseph Farmborough | Chief Technology and Innovation Officer · Since at least Nov 5, 2026 |
| Karen Holzberger | Chief Executive Officer · Since at least Nov 5, 2026 |
| Lil Bianchi | Non-Executive Director and Non-Executive Chair of the Board · Since at least Sep 22, 2026 |
All 13 people
| Person | Seat |
|---|---|
| Natalie Climo | Company Secretary · Since at least Nov 5, 2026 |
| Sasha Grant | Head of Growth, PainChek Infant App · Since at least Nov 5, 2026 |
| Tandeep Gill | General Manager & Head of Business Development, UK&I · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about PainChek Ltd.